SciencePower’s is to redefining postbiotics through next-generation fermentation science — bridging discovery, clinical validation, and real-world health applications.
Check back for updates on:
SciencePower is proud to announce that preclinical findings generated by its internal research team will be presented at the upcoming San Antonio Breast Cancer Symposium (SABCS), taking place December 9-12, 2025, as part of our ongoing collaborative program with Mayo Clinic.
Read More
SciencePower, a next-generation postbiotic platform company, today announced that it has entered into a license agreement with Mayo Clinic. The agreement enables collaborative research led by Mayo Clinic investigators to explore the potential of SciencePower’s proprietary postbiotic compositions in breast cancer biology.
Read More